Tetracaine gel vs EMLA cream for percutaneous anaesthesia in children

Area of Science:

• Pediatric Anesthesiology
• Dermatology
• Pain Management

Background:

• Venous cannulation in children often causes significant pain and anxiety.
• Topical anesthetics like EMLA cream are commonly used but have limitations.
• Optimizing pain management during pediatric procedures is crucial for patient comfort and cooperation.

Purpose of the Study:

• To compare the efficacy and safety of tetracaine gel versus EMLA cream for local anesthesia during pediatric venous cannulation.
• To evaluate pain reduction and duration of effect for both topical anesthetic formulations.
• To assess patient-reported pain scores and adverse effects in children undergoing venous cannulation.

Main Methods:

• A randomized, double-blind study involving 60 children aged 3-15 years.
• Comparison of tetracaine gel (1 g, 45 min application) with EMLA cream (2 g, 60 min application).
• Venous cannulation performed at varying times post-anesthetic removal; pain assessed via patient-reported scores.

Main Results:

• Tetracaine gel resulted in significantly lower pain scores compared to EMLA cream (P < 0.02).
• 40-45% of children using tetracaine gel reported no pain, versus only 10% with EMLA cream.
• Tetracaine gel demonstrated effective, rapid, and long-lasting local anesthesia with minor adverse effects.

Conclusions:

• Tetracaine gel is a more effective topical anesthetic than EMLA cream for reducing pain during pediatric venous cannulation.
• Tetracaine gel provides rapid onset, prolonged duration, and safe local anesthesia in pediatric patients.
• The findings support tetracaine gel as a preferred option for improving procedural comfort in children.